Abstract
Background. The etiology of amyotrophic lateral sclerosis (ALS) remains unknown in approximately 90% of cases [1]. A unified mechanism linking environmental mycotoxin exposure, gut-brain axis dysfunction, and motor neuron disease has not been systematically investigated. Hypothesis. Chronic colonization of the gastric mucosa by a mycotoxin-producing mold, concealed beneath a mucosal biofilm and therefore potentially undetectable by standard endoscopy, is proposed to drive sustained motor-neuron hyperexcitability through three concurrent mechanisms: (1) TLR activation on vagal afferent fibers projecting excitatory signals to brainstem motor nuclei via neural spill-over; (2) cross-reactive immune attack on motor-neuron surface proteins via molecular mimicry; and (3) Dectin-1-mediated neuroinflammation during biofilm disruption. Case. Five-year index case: five positive urinary Trichothecene assays including one after a 32-hour fast (internal source confirmed); six immunological assessments, including five CD25 measurements, showing markedly reduced measured T-cell activation markers and cytokine responses (CD25 1.0–3.1%, reference 13–24%; IFN-γ 79.5 pg/ml, reference ≥118; IL-17 5.4 pg/ml, reference ≥9.6); EMG-confirmed neurogenic remodeling followed by documented stabilization; over 30 reproducible pharmacological observations consistent with the proposed mechanism; and formal diagnostic exclusion across four institutions over three years. Implications. Convergent findings from the published literature, together with more than 30 internally consistent pharmacological observations, support formal investigation of the proposed model. Proposed initial investigations include urinary mycotoxin testing, lymphocyte transformation testing, mycotoxin antibody testing, visual contrast sensitivity screening, and biofilm-directed endoscopy with confocal laser endomicroscopy, targeted biopsy, and PCR analysis.